Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126690351 | 12669035 | 1 | I | 20130729 | 20130826 | 20160819 | 20160819 | EXP | NL-LRB-158137 | NL-009507513-1308NLD012039 | MERCK | 63.00 | YR | F | Y | 0.00000 | 20160819 | OT | NL | NL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126690351 | 12669035 | 1 | PS | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 1 TIME PER 1 DAY 40 MG | 19766 | 40 | MG | FILM-COATED TABLET | QD | ||||||
| 126690351 | 12669035 | 2 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 1 TIMES PER 1 DAYS 40 MG | U | 0 | 40 | MG | CAPSULE | QD | ||||||
| 126690351 | 12669035 | 3 | C | IBUPROFEN. | IBUPROFEN | 1 | 2 TIMES PER 1 DAYS 600 MG | U | 0 | 600 | MG | BID | |||||||
| 126690351 | 12669035 | 4 | C | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 2 TIMES PER 1 DAYS 1 DF | U | 0 | 1 | DF | BID | |||||||
| 126690351 | 12669035 | 5 | C | FLUTICASONE FUROATE | FLUTICASONE FUROATE | 1 | 2 TIMES PER 1 DAYS 1 DF | U | 0 | 1 | DF | BID | |||||||
| 126690351 | 12669035 | 6 | C | calcium carbonate (+) cholecalciferol | CALCIUM CARBONATECHOLECALCIFEROL | 1 | 1 TIMES PER 1 DAYS | U | 0 | 1 | DF | QD | |||||||
| 126690351 | 12669035 | 7 | C | PRAMIPEXOLE. | PRAMIPEXOLE | 1 | 3 TIMES PER 1 DAYS | U | 0 | .25 | MG | TID | |||||||
| 126690351 | 12669035 | 8 | C | OXAZEPAM. | OXAZEPAM | 1 | 5 TIMES PER 1 DAYS 10 MG | U | 0 | 10 | MG | ||||||||
| 126690351 | 12669035 | 9 | C | ZOLPIDEM TARTRATE. | ZOLPIDEM TARTRATE | 1 | 1 TIMES PER 1 DAYS | U | 0 | 10 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126690351 | 12669035 | 1 | Hypercholesterolaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126690351 | 12669035 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126690351 | 12669035 | Muscle rupture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126690351 | 12669035 | 1 | 20121210 | 0 | ||
| 126690351 | 12669035 | 3 | 20130729 | 0 |